Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
April 20, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the first quarter...
Cytek® Biosciences Introduces New 20-Color AML Panel
March 07, 2023 17:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the launch of a new 20-Color Acute Myeloid...
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023 16:05 ET
|
Cytek Biosciences, Inc.
Full year 2022 revenue increased 28%, or 34% on constant currency basis, compared to prior year Provides full year 2023 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over...
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
February 28, 2023 09:21 ET
|
Cytek Biosciences, Inc.
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly...
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
February 13, 2023 16:07 ET
|
Cytek Biosciences, Inc.
Sale of assets related to Flow Cytometry & Imaging (FCI) Business UnitAcquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven flow cytometry to...
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
February 07, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter...
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
February 07, 2023 09:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that it has entered...
Cytek Biosciences to Participate in Upcoming Investor Conferences
February 06, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the following...
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
November 21, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the upcoming Piper...
Cytek® Biosciences Introduces Cytek Cloud
November 15, 2022 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of Cytek Cloud – a cloud-based platform that features two integrated tools to...